MedTrace Logo

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.

NCT03766425 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-10-27

No results posted yet for this study

Summary

Comparison of efficacy and safety of Mitomycin and Aflibercept used to support primary trabeculectomy - a prospective, randomized trial in patients with open-angle glaucoma undergoing surgery.

Conditions

  • Eye Diseases
  • Optic Nerve Damage
  • Glaucoma Surgery

Interventions

DRUG

Aflibercept

subconjunctival injection

DRUG

Mitomycin

subconjunctival injection

Sponsors & Collaborators

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Tomasz Żarnowski, PhD · Medical Uniwersity of Lublin al. Racławickie 1 20-059 Lublin

  • Justyna Kaproń-Swiś, MD · Medical Uniwersity of Lublin al. Racławickie 1 20-059 Lublin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03766425 on ClinicalTrials.gov